Plain-English translation of NCT07909486 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial studies vagus nerve stimulation (VNS) in people with refractory epilepsy—seizures that don't respond well to medication. Researchers want to identify which patients will benefit most from this device and better understand how it works to reduce seizures. By comparing people who respond well to the treatment with those who don't, scientists hope to discover biomarkers that can predict who will have the best outcomes.
Despite having medications available, some people with epilepsy continue to have frequent, uncontrolled seizures. This treatment offers hope for those patients, but doctors don't yet know which patients will respond best or exactly how the device helps the brain control seizures.
You likely qualify if…
You likely don't qualify if…
You will be enrolled in a study that tracks you before and after your vagus nerve stimulation device is implanted. Researchers will collect information and measurements at different time points to see how your body responds to the treatment and to identify patterns that predict who benefits most from this procedure.
AI-generated summary from trial data · Nov 11, 2026 · Not medical advice
Belgium
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Enrollment target
~20 participants
Started
February 2022
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 79 Years
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Riëm EL TAHRY, Pr.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.